TYISHA DAVIS: Open Payments
NPI 1275121055 · FRIENDSWOOD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,921 in 204 payments from 21 companies in 2025. Trend: 2023 $2,855 · 2024 $4,205 · 2025 $3,921
Food & beverage: $3,912Education: $10
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 27 | $560 |
| ABBVIE INC. | 38 | $527 |
| Axsome Therapeutics, Inc. | 18 | $510 |
| Janssen Pharmaceuticals, Inc | 13 | $443 |
| E.R. Squibb & Sons, L.L.C. | 12 | $302 |
| Corium, LLC | 14 | $209 |
| Otsuka America Pharmaceutical, Inc. | 11 | $207 |
| Supernus Pharmaceuticals, Inc. | 13 | $205 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $194 |
| Neurocrine BioSciences, Inc. | 9 | $173 |
Products named: CAPLYTA, VRAYLAR, Auvelity, REXULTI, COBENFY, INVEGA SUSTENNA, Azstarys, Qelbree.
Industry payments across TX — which companies pay providers there.
